PKCα Isoform Inhibits Insulin Signaling and Aggravates Neuronal Insulin Resistance

Area of Science:

• Neuroscience
• Metabolic Disorders
• Cellular Signaling

Background:

• Protein kinase C alpha (PKCα) role in insulin signaling is controversial and tissue-specific.
• Previous studies linked PKCα overexpression to inhibited insulin signaling in skeletal muscle, but its precise role remains unclear.
• The function of PKCα in neuronal insulin resistance and diabetes requires further investigation.

Purpose of the Study:

• To elucidate the role of PKCα in neuronal insulin signaling and insulin resistance.
• To investigate the molecular mechanisms by which PKCα affects insulin sensitivity in neuronal cells.
• To explore the potential of targeting PKCα for treating metabolic and neurodegenerative disorders.

Main Methods:

• Utilized neuronal cell lines (Neuro-2a, SHSY-5Y) and insulin-resistant diabetic mouse brain tissues.
• Investigated the interaction of PKCα with insulin signaling pathway components, including IRS-Akt, PP2A, AS160, 14-3-3ζ, and GSK3 isoforms.
• Assessed the effects of PKCα inhibition and silencing on GLUT-4 translocation, glucose uptake, and insulin sensitivity.

Main Results:

• PKCα was demonstrated to inhibit insulin signaling in neuronal cells via an IRS-Akt pathway, involving PP2A and 14-3-3ζ, independently of AS160.
• Inhibition or silencing of PKCα improved insulin sensitivity, increased GLUT-4 translocation to the plasma membrane, and enhanced glucose uptake.
• PKCα differentially regulated GSK3 isoforms, with higher activity exacerbating insulin resistance in a GSK3β-dependent manner.

Conclusions:

• PKCα plays a significant role in regulating insulin signaling and contributing to neuronal insulin resistance and diabetes.
• Targeting PKCα presents a promising therapeutic strategy for metabolic disorders and neurodegenerative conditions.
• The findings provide mechanistic insights into PKCα's contribution to neuronal dysfunction in diabetes.